What is Sparrow Pharmaceuticals worth?
$139.0Mlast known valuation
Sparrow Pharmaceuticals last raised $95.0M in its Later Stage VC (Series B) (Sep 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Sparrow Pharmaceuticals
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Later Stage VC (Series B) | $95.0M | ▮ | ▮ |
| Apr 2024 | Early Stage VC | $10.0M | ▮ | ▮ |
| Dec 2020 | Seed Round | $1.1M | ▮ | ▮ |
| Aug 2018 | Seed Round | $338K | ▮ | ▮ |
How Sparrow Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Sparrow Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Sparrow Pharmaceuticals worth?
- Sparrow Pharmaceuticals's last known valuation is $139.0M.
- How much has Sparrow Pharmaceuticals raised?
- Sparrow Pharmaceuticals has raised $145.8M in total funding across 4 recorded rounds.
- When did Sparrow Pharmaceuticals last raise?
- Sparrow Pharmaceuticals last raised in Sep 2025 (Later Stage VC (Series B)), raising $95.0M.